Study data, published in JAMA and presented at EMUC 2025, suggest ExactVu is potential MRI alternative for image-guided prostate biopsy Exact Imaging today announced results from its OPTIMUM clinical ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
Exact Imaging reported it has closed on $10 million in financing in a round led by iGan Partners. The Toronto-based company ...
The 'game-changing' technology proved just as effective as MRI at diagnosing the disease but was cheaper and easier to use, researchers said. It could allow doctors to provide a 'one-stop shop' where ...
Exact Imaging Reports Strong Momentum Driven by Commercial Execution and Clinical Validation in 2025
Exact Imaging, a global leader in high-resolution micro-ultrasound systems for prostate cancer, today reported strong business momentum in calendar year 2025, reflecting progress across commercial ...
CNW/ - Exact Imaging, a leader in high-resolution micro-ultrasound for urologic imaging, today announced the closing of a $10 million financing round led ...
Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results